NEOCEPT
Agglutination Method, Human Chorionic Gonadotropin
ORGANON, INC.
The following data is part of a premarket notification filed by Organon, Inc. with the FDA for Neocept.
Pre-market Notification Details
| Device ID | K811941 |
| 510k Number | K811941 |
| Device Name: | NEOCEPT |
| Classification | Agglutination Method, Human Chorionic Gonadotropin |
| Applicant | ORGANON, INC. 803 N. Front St. Suite 3 Mchenry, IL 60050 |
| Product Code | JHJ |
| CFR Regulation Number | 862.1155 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 1981-07-06 |
| Decision Date | 1981-07-27 |
Trademark Results [NEOCEPT]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NEOCEPT 73201065 1165989 Dead/Cancelled |
Organon Inc. 1979-01-22 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.